Antiviral options for biodefense

被引：4

作者：

Byrd, Chelsea M. ^{[1
]}

Grosenbach, Douglas W. ^{[1
]}

Hruby, Dennis E. ^{[1
]}

机构：

[1] SIGA Technol Inc, Corvallis, OR 97333 USA

来源：

CURRENT OPINION IN VIROLOGY | 2013年 / 3卷 / 05期

关键词：

ANTIPOXVIRUS COMPOUND ST-246; IN-VIVO; ARENAVIRUS INHIBITORS; SMALL-MOLECULE; ECZEMA VACCINATUM; SMALLPOX VACCINEE; HUMAN VOLUNTEERS; MONKEYPOX VIRUS; DRUG ST-246; EFFICACY;

D O I：

10.1016/j.coviro.2013.05.020

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A key to biodefense strategies is an assessment of current therapies available as well as the expedited development of new antiviral therapeutic options. Viruses make up the majority of the National Institute of Allergy and Infectious Diseases (NIAID) Category A Priority Pathogens, agents that are considered to pose the greatest risk to public health and national security, and yet there are currently no approved treatments for most of these viral biodefense threats. A review of the Category A viral biothreat agents and strategies for the development of new therapeutics are presented here.

引用

页码：537 / 541

页数：5

共 50 条

[21] A shocking biodefense editorial
Vanderwagen, W. Craig
[J]. NATURE BIOTECHNOLOGY, 2007, 25 (10) : 1083 - 1083
[22] BIODEFENSE LAB UPDATE
Hess, Glenn
[J]. CHEMICAL & ENGINEERING NEWS, 2011, 89 (12) : 32 - 35
[23] On the front lines of biodefense
不详
[J]. VETERINARY ECONOMICS, 2003, 44 (06): : 6 - 6
[24] Antivirals in medical biodefense
Bugert, J. J.
Hucke, F.
Zanetta, P.
Bassetto, M.
Brancale, A.
[J]. VIRUS GENES, 2020, 56 (02) : 150 - 167
[25] Biodefense budget debate
不详
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2002, 50 (01) : 8 - 8
[26] Mass spectrometry in biodefense
Demirev, Plamen A.
Fenselau, Catherine
[J]. JOURNAL OF MASS SPECTROMETRY, 2008, 43 (11): : 1441 - 1457
[27] Monkeypox treatment options: current status of antiviral drugs - a correspondence
Ganapthy, Dhanraj
Sekaran, Saravanan
Rajamani Sekar, Suresh Kumar
[J]. INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (03) : 562 - 563
[28] Antiviral Treatment Options for Severe Fever with Thrombocytopenia Syndrome Infections
Zhang, Yin
Huang, Ying
Xu, Yuanhong
[J]. INFECTIOUS DISEASES AND THERAPY, 2022, 11 (05) : 1805 - 1819
[29] Billions for biodefense: Federal agency biodefense funding, FY2008-FY2009
Franco, Crystal
[J]. BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE, 2008, 6 (02) : 131 - 146
[30] Antiviral Treatment Options for Severe Fever with Thrombocytopenia Syndrome Infections
Yin Zhang
Ying Huang
Yuanhong Xu
[J]. Infectious Diseases and Therapy, 2022, 11 : 1805 - 1819

← 1 2 3 4 5 →